Intravesical p21 mRNA–LNPs: Advancing Bladder Cancer Therapy
2026-06-19
This study introduces a localized, non-viral therapeutic approach for bladder cancer using p21 mRNA–loaded lipid nanoparticles (LNPs) delivered intravesically. The strategy restores tumor suppressor function, significantly suppresses tumor growth, and highlights the translational potential of mRNA–LNP platforms for urologic malignancies.
O-GlcNAcylation Drives Wnt-Induced Bone Formation via Glycol
2026-06-19
The reference study uncovers how O-GlcNAcylation regulates Wnt-stimulated bone formation by rewiring aerobic glycolysis in osteoblasts. This mechanistic insight highlights the significance of metabolic modulation in osteogenesis and provides a foundation for new therapeutic strategies targeting bone disorders.
Acetylcysteine in Tumor Microenvironment: Mechanisms & Model
2026-06-18
Explore acetylcysteine's unique role in tumor microenvironment modeling and oxidative stress pathway modulation. This in-depth analysis uncovers new mechanistic insights and protocol considerations for advanced cancer and disease research.
BMS 309403: Advanced Insights into FABP4 Inhibition for Athe
2026-06-18
Explore the scientific depth and translational utility of BMS 309403, a potent FABP4 inhibitor, in atherosclerosis and metabolic disease research. Unique mechanistic perspectives and protocol guidance set this comprehensive review apart.
EdU Imaging Kits (Cy5): Reliable S-Phase Cell Proliferation
2026-06-17
This article translates real laboratory scenarios into practical, evidence-based guidance on deploying EdU Imaging Kits (Cy5) (SKU K1076) for precise, reproducible S-phase DNA synthesis measurement. Emphasizing workflow safety, data quality, and compatibility, it synthesizes current literature and expert practice to help researchers optimize cell proliferation, cytotoxicity, and genotoxicity studies using click chemistry-based EdU detection.
FPH1 (BRD-6125): Enhancing Functional Proliferation of Hepat
2026-06-17
FPH1 (BRD-6125) is a small molecule that enables robust, donor-independent proliferation of primary human hepatocytes in vitro. It increases albumin secretion, elevates CYP3A4 enzyme expression, and supports functional maturation during iPS cell-to-hepatocyte differentiation. This article details its mechanism, benchmarks, and practical integration for research and cell therapy workflows.
Rucaparib (AG-014699): Redefining DNA Repair and Cell Death
2026-06-16
Explore how Rucaparib (AG-014699) enables translational researchers to probe the nexus of DNA repair, radiosensitization, and regulated apoptosis, bridging mechanistic advances in the DNA damage response with actionable strategic guidance for next-generation cancer biology research.
Trilaurin (Glycerol Tridodecanoate): Mechanisms and Benchmar
2026-06-16
Trilaurin, also known as Glycerol Tridodecanoate, is a multifunctional triacylglycerol C12 excipient with proven utility in biocatalytic synthesis and advanced oral drug delivery. Recent evidence highlights its role in enhancing the oral bioavailability of peptide/protein drugs and facilitating dual chemo-magnetothermal therapy in colorectal cancer. Protocol-driven use of Trilaurin optimizes yield, stability, and safety in both pharmaceutical and biochemical workflows.
CNQX in Translational Neurocardiology: Mechanistic and Strat
2026-06-15
This article explores how CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) enables precise mechanistic dissection of glutamatergic circuits in the central nervous system, focusing on its role in translational research bridging neuroscience and cardiovascular physiology. Drawing from recent findings in the caudal nucleus tractus solitarius (cNTS), we discuss how CNQX distinguishes AMPA/kainate-mediated signaling from NMDA-dependent pathways, empowering researchers to unravel neurogenic control of sympathetic activity and blood pressure. Strategic guidance highlights CNQX’s utility, protocol considerations, and competitive landscape, with a forward-looking perspective on its place in neurocardiovascular translational workflows.
Prednisolone in Glucocorticoid Signaling Research: Advanced
2026-06-15
Prednisolone, a high-purity synthetic glucocorticoid, accelerates research into inflammation and immunology by enabling robust, reproducible glucocorticoid signaling assays. This guide details optimized protocols, troubleshooting, and the integration of cutting-edge targeted protein degradation strategies, translating recent benchmarks into actionable laboratory insights.
hiPSC-Derived Intestinal Organoids for PK and Drug Metabolis
2026-06-14
This study presents a streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with robust self-renewal and differentiation capacity, enabling more accurate in vitro pharmacokinetic studies. The findings bridge critical gaps in modeling human intestinal drug metabolism and transporter activity, offering researchers a scalable alternative to traditional animal and Caco-2 models.
Honokiol Triggers Paraptosis in APL via mTOR and MAPK Pathwa
2026-06-13
This study demonstrates that honokiol induces a caspase-independent, paraptosis-like cell death in acute promyelocytic leukemia (APL) NB4 cells, mediated by activation of mTOR and MAPK signaling. The findings highlight paraptosis as a potential therapeutic strategy for APL, especially for cases resistant to conventional apoptosis-based treatments.
Reserpine (N1867): Technical Guidance for Laboratory Researc
2026-06-12
Reserpine (SKU N1867) is a high-purity, research-grade natural product suited for laboratory workflows investigating neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology. It should not be used in diagnostic, clinical, or veterinary settings, and strict adherence to solubility and stability requirements is essential for reliable results.
Phenothiazines Boost Macrophage Immunity via ROS and Autopha
2026-06-12
The referenced study demonstrates that phenothiazines, including perphenazine, enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) accumulation and autophagy. These findings highlight a promising host-directed therapeutic approach against intracellular bacterial infections, with potential to inform future translational research in immunomodulation.
HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Advanced Pro
2026-06-11
The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit empowers researchers to generate high-yield, customizable fluorescent RNA probes for sensitive in situ hybridization and Northern blot assays. Its optimized protocols and robust chemistry deliver reproducibility, flexibility, and superior signal—redefining standards for RNA probe synthesis in translational and basic research.
466 records 15/32 page Previous Next First page 上5页 1112131415 下5页 Last page